Health
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer – PRNewswire
/PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI)…
SILVER SPRING, Md., April 9, 2021 /PRNewswire/ — Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
“Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with…
-
General22 hours agoPolice offer ‘surrender plan’ to Dezi Freeman as fugitive avoids capture for another day
-
General21 hours agoGeelong Cats AFL star Bailey Smith details mental health battle during All-Australian speech
-
Noosa News12 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
Noosa News20 hours agoQld nurses poised to strike deal with Crisafulli government